Soleno Therapeutics (NASDAQ:SLNO) Price Target Raised to $123.00 at Cantor Fitzgerald
Soleno Therapeutics (NASDAQ:SLNO – Free Report) had its price target increased by Cantor Fitzgerald from $67.00 to $123.00 in a research note issued to investors on Thursday,Benzinga reports. They currently have an overweight rating on the stock. SLNO has been the topic of a number of other research reports. Robert W. Baird boosted their price […]
Soleno Therapeutics (NASDAQ:SLNO – Free Report) had its price target increased by Cantor Fitzgerald from $67.00 to $123.00 in a research note issued to investors on Thursday,Benzinga reports. They currently have an overweight rating on the stock. SLNO has been the topic of a number of other research reports. Robert W. Baird boosted their price […]
